The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant industry tailwinds.
While momentum can be a leading indicator, it has burned many investors as it doesn’t always correlate with long-term success. Keeping that in mind, here are three overhyped stocks that may correct and some you should consider instead.
Stanley Black & Decker (SWK)
One-Month Return: +12%
With an iconic “STANLEY” logo which has remained virtually unchanged for over a century, Stanley Black & Decker (NYSE:SWK) is a manufacturer primarily catering to the tool and outdoor equipment industry.
Why Do We Steer Clear of SWK?
- Absence of organic revenue growth over the past two years suggests it may have to lean into acquisitions to drive its expansion
- Demand will likely be weak over the next 12 months as Wall Street expects flat revenue
- Earnings per share have contracted by 15.9% annually over the last five years, a headwind for returns as stock prices often echo long-term EPS performance
At $98.75 per share, Stanley Black & Decker trades at 17.1x forward P/E. Read our free research report to see why you should think twice about including SWK in your portfolio.
Repligen (RGEN)
One-Month Return: +31.5%
With over 13 strategic acquisitions since 2012 to build its comprehensive bioprocessing portfolio, Repligen (NASDAQ:RGEN) develops and manufactures specialized technologies that improve the efficiency and flexibility of biological drug manufacturing processes.
Why Should You Sell RGEN?
- Day-to-day expenses have swelled relative to revenue over the last five years as its adjusted operating margin fell by 16.2 percentage points
- Earnings per share have dipped by 3.8% annually over the past five years, which is concerning because stock prices follow EPS over the long term
- Shrinking returns on capital from an already weak position reveal that neither previous nor ongoing investments are yielding the desired results
Repligen’s stock price of $180.19 implies a valuation ratio of 77.7x forward P/E. Check out our free in-depth research report to learn more about why RGEN doesn’t pass our bar.
NBT Bancorp (NBTB)
One-Month Return: -0.4%
Tracing its roots back to 1856 when it first opened its doors in Norwich, New York, NBT Bancorp (NASDAQ:NBTB) is a community-oriented financial institution providing banking, wealth management, and insurance services to individuals and businesses across the northeastern United States.
Why Do We Think Twice About NBTB?
- Muted 9.7% annual revenue growth over the last five years shows its demand lagged behind its banking peers
- Estimated net interest income growth of 5.8% for the next 12 months implies demand will slow from its five-year trend
- Incremental sales over the last five years were less profitable as its 3% annual earnings per share growth lagged its revenue gains
NBT Bancorp is trading at $51.87 per share, or 1.3x forward P/B. To fully understand why you should be careful with NBTB, check out our full research report (it’s free).
Stocks We Like More
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.